(Glu2)-TRH is a modified form of thyrotropin-releasing hormone featuring a glutamic acid substitution that shifts charge characteristics and spatial configuration. This variation provides a tool for evaluating TRH receptor recognition and intracellular signaling. Its altered physicochemical traits contribute to understanding peptide hormone regulation. Researchers frequently use it in neuroendocrine pathway mapping.
CAT No: T08002
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More